There has been “strong interest” in a Phase 2/3 trial evaluating laru-zova for the treatment of X-linked retinitis pigmentosa (XLRP), according to Beacon Therapeutics.

Topcon Healthcare has taken a leading role in seed funding for OKKO Health, a UK-based software medical device company pioneering innovative approaches to vision

Biopharmaceutical company Boehringer Ingelheim has announced a strategic collaboration with Re-Vana Therapeutics to develop first-in-class extended-release therapies for vision-threatening eye diseases.

A case report from East Africa has highlighted the need for pre- and post-operative psychological care for cataract surgery patients, particularly those who are